Methods for Increasing Expression of Genes In a Fungal Cell
The present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first polynucleotide comprising a nucleic acid sequence encoding the polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor; and (b) isolating the polypeptide from the cultivation medium.
Latest Novozymes, Inc. Patents:
1. Field of the Invention
The present invention relates to methods for increasing expression of genes encoding polypeptides in a fungal cell.
2. Description of the Related Art
The recombinant production of a native or foreign polypeptide in a fungal host cell. e.g., a yeast or filamentous fungal cell, may provide for a more desirable vehicle for producing the polypeptide in commercially relevant quantities.
Recombinant production of a native or foreign polypeptide is generally accomplished by constructing an expression cassette in which the DNA coding for the polypeptide is placed under the expression control of a promoter from a regulated gene. The expression cassette is introduced into the host cell, usually by plasmid-mediated transformation. Production of the polypeptide is then achieved by culturing the transformed host cell under inducing conditions necessary for the proper functioning of the promoter contained on the expression cassette.
The development of new expression constructs and vectors for the recombinant production of polypeptides in a fungal host cell generally requires the availability of efficient promoters that are suitable for controlling expression of the polypeptides in the host cell. However, even the best known promoters can be inefficient for expressing a gene of interest.
Many promoters are susceptible to being modulated which can increase their efficiency. The Saccharomyces cerevisiae metallothionein gene, designated CUP1, is transcriptionally activated by copper through a specific promoter region, UASCUP1 (upstream activation sequence), reportedly located between −105 and −230 with respect to the CUP1 transcription activation site (Thiele and Hamer, 1986, Mol. Cell. Biol. 6: 1158-1163; Zhou and Thiele, 1993, Biofactors 4: 105-115). The Ace1 protein (Ace1p) of Saccharomyces cerevisiae is responsible for induction of the yeast metallothionein gene CUP1, in the presence of copper ions (Thiele, 1988, Mol. Cell. Biol. 8: 2745-2752) or silver ions (Furst et al., 1988, Cell 55: 705-717). The amino-terminal half of the Ace1p is rich in basic amino acid residues and cysteines and specifically binds to the CUP1 upstream activator sequence in the presence, but not in the absence, of Cu(I) or Ag(I) (Furst et al., 1988, supra). Thiele and Hamer, 1986, Molecular and Cellular Biology 6: 1158-1163, disclose that tandemly duplicated upstream control sequences mediate copper-induced transcription of the Saccharomyces cerevisiae copper-metallothionein gene and a synthetic version of one of these elements confers copper induction on a heterologous promoter when present in two tandem copies.
Gralla et al., 1991, PNAS USA 88: 8558-8562, disclose that Ace1p activates expression of a yeast copper, zinc superoxide dismutase gene. Lapinskas et al., 1993, Current Genetics 24: 388-393, disclose that Ace1p activates expression of a Saccharomyces cerevisiae cytosolic catalase gene.
Mehra et al., 1989, J. Biological Chemistry 264: 19747-19753, describe the cloning and sequences of metallothionein genes from Candida glabrata. Zhou and Thiele, 1991, PNAS USA 88: 6112-6116, describe the isolation of a metal-activated transcription factor gene from Candida glabrata. Thorvaldsen et al., 1993, J. Biological Chemistry 268: 12512-12518, disclose the regulation of the Candida glabrata metallothionein genes, designated MTI, MTIIa, and MTIIb, by AMT1.
Mascorro-Gallardo et al., 1996, Gene 172: 169-170, disclose construction of a CUP1 promoter-based vector to modulate gene expression in Saccharomyces cerevisiae. Macreadie et al., 1989, Plasmid 21: 147-150, disclose a series of yeast expression vectors utilizing the CUP1 gene of Saccharomyces cerevisiae. Hottiger et al., 1994, Yeast 10: 283-296, disclose the physiological characterization of the CUP1 promoter and consequences of overexpressing its transcriptional activator Ace1p.
It is an object of the present invention to provide improved methods for producing a polypeptide in a fungal host cell.
SUMMARY OF THE INVENTIONThe present invention relates to methods for producing a polypeptide, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first polynucleotide comprising a nucleic acid sequence encoding the polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor; and (b) isolating the polypeptide from the cultivation medium. The polypeptide may be native or foreign to the fungal host cell.
The present invention also relates to fungal host cells comprising a first polynucleotide comprising a nucleic acid sequence encoding a polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor.
The present invention further relates to nucleic acid constructs and vectors comprising a first polynucleotide comprising a nucleic acid sequence encoding a polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence.
The present invention relates to methods for producing a polypeptide, comprising (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first polynucleotide comprising a nucleic acid sequence encoding the polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor; and (b) isolating the polypeptide from the cultivation medium.
In the production methods of the present invention, the fungal host cells are cultivated in a nutrient medium suitable for production of the polypeptide using methods known in the art. For example, the cell may be cultivated by shake flask cultivation, or small-scale or large-scale fermentation (including continuous, batch, fed-batch, or solid state fermentations) in laboratory or industrial fermentors. The cultivation takes place in a suitable nutrient medium comprising carbon, nitrogen sources, inorganic salts, and copper ions (and/or silver ions), using procedures known in the art. Suitable media are available from commercial suppliers or may be prepared according to published compositions (e.g., in catalogues of the American Type Culture Collection). When copper ions are present in the medium, the medium contains at least 10 μM copper eons, preferably at least 50 μM copper ions, more preferably at least 100 μM copper ions, even more preferably at least 250 μM, and most preferably at least 500 μM copper ions. The copper ions can be added to the medium in the form of CuSO4, CuCl2, or any other suitable form. The medium can also or alternatively contain silver ions. When silver is present in the medium, the medium contains at least 10 μM silver ions, preferably at least 50 μM silver ions, more preferably at least 100 μM silver ions, even more preferably at least 250 μM silver ions, and most preferably at least 500 μM silver ions. The silver ions can be added to the medium in the form of Ag2SO4, AgCl, or any other suitable form.
The polypeptide may be detected using methods known in the art that are specific for the polypeptide. These detection methods may include use of specific antibodies, high performance liquid chromatography, capillary chromatography, formation of an enzyme product, disappearance of an enzyme substrate, or SDS-PAGE.
For example, where the polypeptide is an enzyme, an enzyme assay may be used to determine the activity of the enzyme. Procedures for determining enzyme activity are known in the art for many enzymes (see, for example, D. Schomburg and M. Salzmann (eds.), Enzyme Handbook, Springer-Verlag, New York, 1990).
If the polypeptide is secreted into the nutrient medium, the substance can be recovered directly from the medium. If the polypeptide is not secreted, it can be recovered from cell lysates. The resulting polypeptide may be isolated using methods known in the art. For example, the polypeptide may be isolated from the cultivation medium by conventional procedures including, but not limited to, centrifugation, filtration, extraction, spray-drying, evaporation, and/or precipitation. The isolated polypeptide may then be further purified by a variety of procedures known in the art including, but not limited to, chromatography (e.g., ion exchange, affinity, hydrophobic, chromatofocusing, and size exclusion), electrophoretic procedures (e.g., preparative isoelectric focusing (IEF), differential solubility (e.g., ammonium sulfate precipitation), or extraction (see, e.g., Protein Purification, J.-C. Janson and Lars Ryden, editors, VCH Publishers, New York, 1989).
A fungal host cell of the present invention comprising a first polynucleotide comprising a nucleic acid sequence encoding the polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor, produces at least 10%, preferably at least 25%, more preferably at least 50%, even more preferably at least 75%, most preferably at least 100%, and even most preferably at least 200% more polypeptide than a fungal host cell without a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, and/or a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor.
PromotersThe term “promoter” is defined herein as a DNA sequence that binds RNA polymerase and directs the polymerase to the correct downstream transcriptional start site of a polynucleotide comprising a nucleic acid sequence encoding a polypeptide to initiate transcription, RNA polymerase effectively catalyzes the assembly of messenger RNA complementary to the appropriate DNA strand of the coding region. The term “promoter” will also be understood to include the 5′ non-coding region (between promoter and translation start) for translation after transcription into mRNA, cis-acting transcription control elements such as transcriptional activators, and other nucleotide sequences capable of interacting with transcription factors.
The term “copper-inducible promoter sequence” is defined herein as a promoter that is induced by copper ions via a cis-acting element as a component of the promoter, which possesses binding sites for transcriptional regulatory factors that are responsible for copper-induced transcription of the promoter.
The term “tandem promoter” is defined herein as two or more promoter sequences each of which is operably linked to a coding sequence and mediates transcription of the coding sequence into mRNA. The components of the tandem promoter may be the same promoter or a combination of different promoters. The promoters can be obtained from genes encoding extracellular or intracellular polypeptides either native or foreign to the host cell. At least one of the promoters contained in the tandem promoter is a copper-inducible promoter. In a preferred aspect, the tandem promoter is composed of copper-inducible promoters.
The term “hybrid promoter” is defined herein as a promoter sequence that is composed of portions of two or more promoters operably linked to a coding sequence and mediates transcription of the coding sequence into mRNA. The promoters can be obtained from genes encoding extracellular or intracellular polypeptides either native or foreign to the host cell. At least one portion of the hybrid promoter is a portion of a copper-inducible promoter. In a preferred aspect, the hybrid promoter is composed of portions of two or more copper-inducible promoters.
The term “operably linked” is defined herein as a configuration in which a control sequence, e.g., a promoter sequence, is appropriately placed at a position relative to a coding sequence such that the control sequence directs the production of a polypeptide encoded by the coding sequence.
The term “coding sequence” is defined herein as a nucleic acid sequence that is transcribed into mRNA which is translated into a polypeptide, e.g., enzyme, when placed under the control of the appropriate control sequences. The boundaries of the coding sequence are generally determined by an open reading frame, which usually begins with the ATG start codon or alternative start codons such as GTG and TTG, and ends with a stop codon such as TAA, TAG and TGA. A coding sequence can include, but is not limited to, genomic DNA, cDNA, semisynthetic, synthetic, and recombinant nucleic acid sequences.
In practicing the methods of the present invention, a copper-inducible promoter can be obtained from a Saccharomyces cerevisiae metallothienein gene, Saccharomyces cerevisiae superoxide dismutase gene, Saccharomyces cerevisiae cytosolic catalase gene, Saccharomyces cerevisiae copper resistant suppressor gene, Candida glabrata metallothionein gene, Neurospora crassa metallothionein gene, Yarrowia lipolytica metallothionein gene, Agaricus bisporus metallothionein gene, Magnaporthe grisea metallothionein gene, and Podospora anserina metallothionein gene.
In a preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae metallothionein gene. In a more preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae CUP1 gene (Accession number P07215) (Butt et al. 1984, PNAS USA 76: 3332-3336) (SEQ ID NO: 1 for DNA and SEQ ID NO: 2 for the deduced amino acid sequence).
In another preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae superoxide dismutase gene. In a more preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae SOD1 gene (Accession number P00445) (Gralla et al., 1991, PNAS USA 88: 8558-8562) (SEQ ID NO: 3 for DNA and SEQ ID NO: 4 for the deduced amino acid sequence).
In another preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae cytosolic catalase gene. In a more preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae CTT1 gene (Accession number P06115) (Lapinskas et al., 1993, Current Genetics 24: 388-393) (SEQ ID NO: 5 for DNA and SEQ ID NO: 6 for the deduced amino acid sequence).
In another preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae copper resistant suppressor gene. In a more preferred aspect, the copper-inducible promoter sequence is obtained from a Saccharomyces cerevisiae CRS5 gene (Accession number P41902) (Culotta et al., 1994, J. Biol. Chem. 269: 25295-252302) (SEQ ID NO: 7 for DNA and SEQ ID NO: 8 for the deduced amino acid sequence).
In another preferred aspect, the copper-inducible promoter sequence is obtained from a Candida glabrata metallothionein gene. In a more preferred aspect, the copper-inducible promoter sequence is obtained from a Candida glabrata MT gene. In a most preferred aspect, the copper-inducible promoter sequence is obtained from a Candida glabrata MTI gene (Accession number P15113) (Mehra et al., 1989, J. Biological Chemistry 264: 19747-19753; Mehra et al., 1992, Gene 114: 75-80; Mehra et al., 1990, Gene 265: 6369-6375) (SEQ ID NO: 9 for DNA and SEQ ID NO: 10 for the deduced amino acid sequence). In another most preferred aspect, the copper-inducible promoter sequence is obtained from a Candida glabrata MTII gene (Accession number J05398) (Mehra et al., 1989, supra; Mehra et al., 1992, supra; Mehra et al., 1990, supra) (SEQ ID NO: 11 for DNA and SEQ ID NO: 12 for the deduced amino acid sequence).
In the methods of the present invention, the copper-inducible promoter may also be a tandem promoter comprising two or more promoters or a hybrid promoter comprising portions of two or more promoters, at least one of which is a copper-inducible promoter or a portion of a copper-inducible promoter.
Examples of promoters that are not copper-inducible promoters but useful in the construction of tandem or hybrid promoters with the copper-inducible promoter(s) include, but are not limited to, the promoters obtained from the genes for Aspergillus oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral alpha-amylase, Aspergillus niger acid stable alpha-amylase, Aspergillus niger or Aspergillus awamori glucoamylase (glaA), Rhizomucor miehei lipase, Aspergillus oryzae alkaline protease, Aspergillus oryzae triose phosphate isomerase, Aspergillus nidulans acetamidase, Fusarium venenatum amyloglucosidase, Fusarium venenatum Daria promote, Fusarium venenatum Quinn promoter, Fusarium oxysporum trypsin-like protease (WO 96/00787), Trichoderma reesei beta-glucosidase, Trichoderma reesei cellobiohydrolase I, Trichoderma reesei cellobiohydrolase II, Trichoderma reesei endoglucanase I, Trichoderma reesei endoglucanase II, Trichoderma reesei endoglucanase III, Trichoderma reesei endoglucanase IV, Trichoderma reesei endoglucanase V, Trichoderma reesei xylanase I, Trichoderma reesei xylanase II, Trichoderma reesei beta-xylosidase, Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae galactokinase (GAL1), Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde-3-phosphate dehydrogenase (ADH2/GAP), and Saccharomyces cerevisiae 3-phosphoglycerate kinase; as well as the NA2-tpi promoter (a hybrid of the promoters from the genes for Aspergillus niger neutral alpha-amylase and Aspergillus oryzae triose phosphate isomerase); and mutant, truncated, and hybrid promoters thereof. Other useful promoters for yeast host cells are described by Romanos et al., 1992, Yeast 8: 423-488.
In the methods of the present invention, the hybrid or tandem promoter will be understood to be foreign to a nucleic acid sequence encoding a polypeptide, even if a wild-type promoter or a portion thereof as a component of the tandem or hybrid promoter is native to the nucleic acid sequence. For example, in a tandem promoter consisting of at least two promoters, one or more (several) of the promoters may be a wild-type promoter of the nucleic acid sequence encoding a polypeptide.
Upstream Activation Sequences (UAS)The term “copper-responsive upstream activation sequence” is defined herein as a region of a promoter comprising a DNA sequence, designated a cis-acting element, which serves as a binding site for transcriptional regulatory factors which are responsible for copper-induced transcription of a promoter. For yeast and filamentous fungal genes, a promoter region containing such a cis-acting element is referred to as an upstream activation sequence, which is abbreviated UAS. (Thiele, 1992, Nucleic Acids Research 20: 1183-1191). Identification and isolation of such a UAS can be accomplished according to the procedures described by Thiele and Hamer, 1986, supra; Zhou and Thiele, 1993, supra; and Thiele, 1992, supra.
In the methods of the present invention, any cis-acting promoter element responsible for copper-induced gene transcription can be used. The copper-responsive upstream activation sequence can be obtained from a copper-inducible promoter of a gene selected from the group consisting of a Saccharomyces cerevisiae metallothienein gene, Saccharomyces cerevisiae superoxide dismutase gene, Saccharomyces cerevisiae cytosolic catalase gene, Saccharomyces cerevisiae copper resistant suppressor gene, Candida glabrata metallothionein gene, Neurospora crassa metallothionein gene, Yarrowia lipolytica metallothionein gene, Agaricus bisporus metallothionein gene. Magnaporthe grisea metallothionein gene, and Podospora anserina metallothionein gene.
In a preferred aspect, the copper-responsive upstream activation sequence is obtained from the promoter of a Saccharomyces cerevisiae metallothionein gene. In a more preferred aspect, the copper-responsive upstream activation sequence is obtained from the promoter of a Saccharomyces cerevisiae CUP1 gene (Accession number P07215) (Butt et al., 1984, supra).
In another preferred aspect, the copper-responsive upstream activation sequence is obtained from the promoter of a Saccharomyces cerevisiae cytosolic catalase gene. In a more preferred aspect, the copper-responsive upstream activation sequence is obtained from the promoter of a Saccharomyces cerevisiae CTT1 gene (Accession number P06115) (Lapinskas et al., 1993, supra).
In another preferred aspect, the copper-responsive upstream activation sequence is obtained from a Saccharomyces cerevisiae superoxide dismutase gene. In a more preferred aspect, the copper-responsive upstream activation sequence is obtained from the promoter of a Saccharomyces cerevisiae SOD1 gene (Accession number P00445) (Gralla et al., 1991, supra).
In another preferred aspect, the copper-responsive upstream activation sequence is obtained from a Saccharomyces cerevisiae copper resistant suppressor gene. In a more preferred aspect, the copper-responsive upstream activation sequence is obtained from the promoter of a Saccharomyces cerevisiae CRS5 gene (Accession number P41902) (Culotta et al., 1994, supra).
In another preferred aspect, the copper-responsive upstream activation sequence is obtained from a Candida glabrata metallothionein gene. In a more preferred aspect, the copper-responsive upstream activation sequence is obtained from a Candida glabrata MT gene. In a most preferred aspect, the copper-responsive upstream activation sequence is obtained from a Candida glabrata MTI gene (Accession number P15113) (Mehra et al., 1989, supra; Mehra et al., 1992, supra; Mehra et al., 1990, supra). In another most preferred aspect, the copper-responsive upstream activation sequence is obtained from a Candida glabrata MTIIa gene (Accession number P15113) (Mehra et al., 1989, supra; Mehra et al., 1992, supra; Mehra et al., 1990, supra). In another most preferred aspect, the copper-responsive upstream activation sequence is obtained from a Candida glabrata MTIIb gene (Accession number P15114) (Mehra et al., 1989, supra; Mehra et al., 1992, supra; Mehra et al., 1990, supra).
In the methods of the present invention, one or more (several) additional copper-responsive upstream activation sequences (UASs) are operably linked upstream to the copper-inducible promoter. It is understood that the copper-inducible promoter will contain its own copper-responsive upstream activation sequencers), and, consequently, the one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter can be the same UAS region as that contained in the promoter, can be a different UAS region from that contained in the promoter, or can be a combination thereof. Depending on the number of copper-responsive elements associated with the upstream activation sequence. i.e., the correlation of the number of copper-responsive elements and the copper-dependent transcriptional potency, more than one upstream activation sequence may be placed upstream of the promoter. Consequently, depending on the number of copper-responsive cis-acting elements contained in an upstream activation sequence, multiple copies of a specific upstream activation sequence can be used, combinations of different upstream activation sequences can be used, or a combination of each of the preceding can be used. The total number of copper-responsive cis-acting elements is at least 2, preferably at least 3, more preferably at least 4, even more preferably at least 5, and most preferably at least 6.
In a preferred aspect, one of the additional copper-responsive upstream activation sequences is SEQ ID NO: 46. In another preferred aspect, one of the additional copper-responsive upstream activation sequences is SEQ ID NO: 47.
Transcriptional Activator GenesThe term “copper-dependent trans-acting transcription factor gene” is defined herein as a gene which encodes a transcription factor that activates gene transcription via a copper-responsive upstream activation sequence (UAS) coupled to a copper-inducible promoter sequence in a copper-dependent manner. Such genes are also called copper metallo-regulatory transcription factor (MRTF) genes. It will be understood that encompassed within the term “copper-dependent trans-acting transcription factor gene”, as used herein, are truncated and/or mutated versions of such a gene.
In the methods of the present invention, any transcriptional activator gene which encodes a transcription factor that activates gene transcription via a copper-responsive upstream activation sequence (UAS) can be used. The transcriptional activator gene can be selected from the group consisting of a Saccharomyces cerevisiae ACE1 gene. Candida glabrata AMT1 gene, Yarrowia lipolytica CRF1 gene (Accession number P45815), Schizosaccharomyces pombe CUF2 gene (Accession number O094588), Saccharomyces cerevisiae HAA1 gene (Accession Number Q12753), and Aspergillus fumigatus copper fist DNA binding domain protein gene (Accession number Q4WN33).
In a preferred aspect, the transcriptional activator gene is a Saccharomyces cerevisiae ACE1 gene (Accession number P15315) (Thiele and Hamer, 1986, Mol. Cell. Biol. 6: 1158-1163) (SEQ ID NO: 13 for DNA and SEQ ID NO: 14 for the deduced amino acid sequence).
In another preferred aspect, the transcriptional activator gene is a Candida glabrata AMT1 gene (Accession number P41772) (Zhou and Thiele, 1991, PNAS USA 88: 6112-6116) (SEQ ID NO: 15 for DNA and SEQ ID NO: 16 for the deduced amino acid sequence).
In another preferred aspect, the transcriptional activator gene is a Yarrowia lipolytica CRF1 gene (Accession number P45815) (SEQ ID NO: 17 for DNA and SEQ ID NO: 18 for the deduced amino acid sequence).
In another preferred aspect, the transcriptional activator gene is a Schizosaccharomyces pombe CUF2 gene (Accession number O94588) (SEQ ID NO: 19 for DNA and SEQ ID NO: 20 for the deduced amino acid sequence).
In another preferred aspect, the transcriptional activator gene is a Saccharomyces cerevisiae HAA1 gene (Accession Number Q12753) (SEQ ID NO: 21 for DNA and SEQ ID NO: 22 for the deduced amino acid sequence).
In another preferred aspect, the transcriptional activator gene is an Aspergillus fumigatus copper fist DNA binding domain protein gene (Accession number Q4WN33) (SEQ ID NO: 23 for DNA and SEQ ID NO: 24 for the deduced amino acid sequence).
In the methods of the present invention, the fungal host cell comprises at least one transcriptional activator gene. The transcriptional activator gene can be native or foreign to the host cell. In a preferred aspect, multiple copies of a transcriptional activator gene are present in the host. Alternatively, a combination of at least two different transcriptional activator genes each present in one or more (several) copies may be present in the fungal host cell. The genes may be native or foreign to the host cell, or a combination thereof.
An increase in the copy number of a transcriptional activator gene can be obtained by integrating at least one additional copy of the gene into the host cell genome or by including an amplifiable selectable marker gene with the transcriptional activator gene where cells containing amplified copies of the selectable marker gene, and thereby additional copies of the transcriptional activator gene, can be selected for by cultivating the cells in the presence of the appropriate selectable agent.
The transcriptional activator gene(s) may be integrated into the chromosome of the host cell or may be present as extrachromosomal elements, or a combination thereof. In a preferred aspect, the transcriptional activator gene(s) is integrated into the chromosome of the host cell.
PolypeptidesThe polypeptide may be native or heterologous to the fungal host cell of interest. The term “heterologous polypeptide” is defined herein as a polypeptide which is not native to the host cell, or a native polypeptide in which structural modifications have been made to alter the native polypeptide.
The polypeptide may be any polypeptide having a biological activity of interest. The term “polypeptide” is not meant herein to refer to a specific length of the encoded product and, therefore, encompasses peptides, oligopeptides, and proteins. The term “polypeptide” also encompasses hybrid polypeptides, which comprise a combination of partial and/or complete polypeptide sequences obtained from at least two different polypeptides wherein one or more (several) may be heterologous to the fungal cell. Polypeptides further include naturally occurring allelic and engineered variations of a polypeptide.
In a preferred aspect, the polypeptide is an antibody, antigen, antimicrobial peptide, enzyme, growth factor, hormone, immunodilator, neurotransmitter, receptor, reporter protein, structural protein, and transcription factor.
In a more preferred aspect, the polypeptide is an oxidoreductase, transferase, hydrolase, lyase, isomerase, or ligase. In a most preferred aspect, the polypeptide is an alpha-glucosidase, aminopeptidase, amylase, carbohydrase, carboxypeptidase, catalase, cellulase, chitinase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, esterase, alpha-galactosidase, beta-galactosidase, glucoamylase, glucocerebrosidase, alpha-glucosidase, beta-glucosidase, invertase, laccase, lipase, mannosidase, mutanase, oxidase, pectinolytic enzyme, peroxidase, phospholipase, phytase, polyphenoloxidase, proteolytic enzyme, ribonuclease, transglutaminase, urokinase, or xylanase.
In another preferred aspect, the polypeptide is an albumin, collagen, tropoelastin, elastin, or gelatin.
The nucleic acid sequence encoding a polypeptide may be obtained from any prokaryotic, eukaryotic, or other source. For purposes of the present invention, the term “obtained from” as used herein in connection with a given source shall mean that the polypeptide is produced by the source or by a cell in which a gene from the source has been inserted.
The techniques used to isolate or clone a nucleic acid sequence encoding a polypeptide are known in the art and include isolation from genomic DNA, preparation from cDNA, or a combination thereof. The cloning of the nucleic acid sequence from such genomic DNA can be effected, e.g., by using the polymerase chain reaction (PCR). See, for example, Innis et al., 1990, PCR Protocols: A Guide to Methods and Application, Academic Press, New York. The cloning procedures may involve excision and isolation of a desired nucleic acid fragment comprising the nucleic acid sequence encoding the polypeptide, insertion of the fragment into a vector molecule, and incorporation of the recombinant vector into the fungal cell where multiple copies or clones of the nucleic acid sequence will be replicated. The nucleic acid sequence may be of genomic, cDNA, RNA, semisynthetic, synthetic origin, or any combinations thereof.
Nucleic Acid ConstructsThe present invention also relates to nucleic acid constructs comprising a first polynucleotide comprising a nucleic acid sequence encoding a polypeptide of interest operably linked to a copper-Inducible promoter sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising at least one copper-responsive upstream activation sequence (UAS) upstream of the promoter, and one or more (several) control sequences which direct the expression of the coding sequence of the polynucleotide in a suitable host cell under conditions compatible with the control sequences. Expression will be understood to include any step involved in the production of the polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
“Nucleic acid construct” is defined herein as a nucleic acid molecule, either single- or double-stranded, which is isolated from a naturally occurring gene or which has been modified to contain segments of nucleic acid combined and juxtaposed in a manner that would not otherwise exist in nature. The term nucleic acid construct is synonymous with the term expression cassette when the nucleic acid construct contains a coding sequence and all the control sequences required for expression of the coding sequence.
An isolated polynucleotide encoding a polypeptide or a copper-dependent trans-acting transcription factor can also be manipulated to provide for improved expression of the polypeptide or the transcription factor. Manipulation of the nucleic acid sequence prior to its insertion into a vector may be desirable or necessary depending on the expression vector. The techniques for modifying nucleic acid sequences utilizing recombinant DNA methods are well known in the art.
In the methods of the present inventions the nucleic acid sequence encoding a polypeptide or a copper-dependent trans-acting transcription factor may comprise one or more (several) native control sequences or one or more (several) of the native control sequences may be replaced with one or more (several) control sequences foreign to the nucleic acid sequence for improving expression of the coding sequence in a host cell.
The term “control sequences” is defined herein to include all components which are necessary or advantageous for the expression of a polypeptide. Each control sequence may be native or foreign to the nucleic acid sequence encoding the polypeptide. In addition to the copper-inducible promoter(s) and copper-responsive upstream activation sequence(s) described herein, such control sequences include, but are not limited to, a promoter, leader, polyadenylation sequence, propeptide sequence, signal peptide sequence, and transcription terminator. At a minimum, the control sequences include a copper-inducible promoter(s), copper-responsive upstream activation sequencers), and transcriptional and translational stop signals. The control sequences may be provided with linkers for the purpose of introducing specific restriction sites facilitating ligation of the control sequences with the coding region of the nucleic acid sequence encoding a polypeptide.
Manipulation of the promoter of a polynucleotide encoding a polypeptide of interest has already been discussed herein. For the copper-dependent trans-acting transcription factor, the control sequence may be an appropriate promoter sequence, a nucleotide sequence which is recognized by a host cell for expression of a polynucleotide encoding the transcription factor. The promoter sequence contains transcriptional control sequences which mediate the expression of the transcription factor. The promoter may be any nucleotide sequence which shows transcriptional activity in the host cell of choice including mutant, truncated, and hybrid promoters, and may be obtained from genes encoding extracellular or intracellular polypeptides either native or foreign to the host cell.
Examples of suitable promoters for directing transcription in a filamentous fungal host cell are promoters obtained from the genes for Aspergillus oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, Aspergillus niger neutral alpha-amylase, Aspergillus niger acid stable alpha-amylase, Aspergillus niger or Aspergillus awamori glucoamylase (glaA). Rhizomucor miehei lipase, Aspergillus oryzae alkaline protease, Aspergillus oryzae triose phosphate isomerase, Aspergillus nidulans acetamidase, Fusarium venenatum amyloglucosidase (WO 00/56900), Fusarium venenatum Daria (WO 00/56900), Fusarium venenatum Quinn (WO 00/56900), Fusarium oxysporum trypsin-like protease (WO 96/00787), Trichoderma reesei beta-glucosidase, Trichoderma reesei cellobiohydrolase I, Trichoderma reesei cellobiohydrolase II, Trichoderma reesei endoglucanase I, Trichoderma reesei endoglucanase II, Trichoderma reesei endoglucanase III, Trichoderma reesei endoglucanase IV, Trichoderma reesei endoglucanase V, Trichoderma reesei xylanase I, Trichoderma reesei xylanase II, Trichoderma reesei beta-xylosidase, as well as the NA2-tpi promoter (a hybrid of the promoters from the genes for Aspergillus niger neutral alpha-amylase and Aspergillus oryzae triose phosphate isomerase); and mutant, truncated, and hybrid promoters thereof.
In a yeast host, useful promoters are obtained from the genes for Saccharomyces cerevisiae enolase (ENO1), Saccharomyces cerevisiae galactokinase (GAL1), Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde-3-phosphate dehydrogenase (ADH1, ADH2/GAP), Saccharomyces cerevisiae triose phosphate isomerase (TPI), Saccharomyces cerevisiae metallothionine (CUP1), and Saccharomyces cerevisiae 3-phosphoglycerate kinase. Other useful promoters for yeast host cells are described by Romanos et al., 1992, Yeast 8: 423-488.
The control sequence may be a suitable transcription terminator sequence, a sequence recognized by a host cell to terminate transcription. The terminator sequence is operably linked to the 3′ terminus of the nucleic acid sequence encoding the polypeptide. Any terminator which is functional in the fungal host cell of choice may be used in the present invention.
Preferred terminators for filamentous fungal host cells are obtained from the genes for Aspergillus oryzae TAKA amylase. Aspergillus niger glucoamylase, Aspergillus nidulans anthranilate synthase, Aspergillus niger alpha-glucosidase, and Fusarium oxysporum trypsin-like protease.
Preferred terminators for yeast host cells are obtained from the genes for Saccharomyces cerevisiae enolase, Saccharomyces cerevisiae cytochrome C (CYC1), and Saccharomyces cerevisiae glyceraldehyde-3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al., 1992, supra.
The control sequence may also be a suitable leader sequence, a nontranslated region of an mRNA which is important for translation by the host cell. The leader sequence is operably linked to the 5′ terminus of the nucleic acid sequence encoding the polypeptide. Any leader sequence that is functional in the host cell of choice may be used in the present invention.
Preferred leaders for filamentous fungal host cells are obtained from the genes for Aspergillus oryzae TAKA amylase, Aspergillus nidulans triose phosphate isomerase, Fusarium venenatum trypsin, and Fusarium venenatum glucoamylase.
Suitable leaders for yeast host cells are obtained from the genes for Saccharomyces cerevisiae enolase (ENO1), Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae alpha-factor, and Saccharomyces cerevisiae alcohol dehydrogenase/glyceraldehyde-3-phosphate dehydrogenase (ADH2/GAP).
The control sequence may also be a polyadenylation sequence, a sequence operably linked to the 3′ terminus of the nucleic acid sequence and which, when transcribed, is recognized by the host cell as a signal to add polyadenosine residues to transcribed mRNA. Any polyadenylation sequence which is functional in the fungal host cell of choice may be used in the present invention.
Preferred polyadenylation sequences for filamentous fungal host cells are obtained from the genes for Aspergillus oryzae TAKA amylase. Aspergillus niger glucoamylase, Aspergillus nidulans anthranilate synthase, Fusarium oxysporum trypsin-like protease, and Aspergillus niger alpha-glucosidase.
Useful polyadenylation sequences for yeast host cells are described by Guo and Sherman, 1995, Molecular Cellular Biology 15: 5983-5990.
The control sequence may also be a signal peptide coding region that codes for an amino acid sequence linked to the amino terminus of a polypeptide and directs the encoded polypeptide into the cell's secretory pathway. The 5′ end of the coding sequence of the nucleic acid sequence may inherently contain a signal peptide coding region naturally linked in translation reading frame with the segment of the coding region which encodes the secreted polypeptide. Alternatively, the 5′ end of the coding sequence may contain a signal peptide coding region which is foreign to the coding sequence. The foreign signal peptide coding region may be required where the coding sequence does not naturally contain a signal peptide coding region. Alternatively, the foreign signal peptide coding region may simply replace the natural signal peptide coding region in order to enhance secretion of the polypeptide. However, any signal peptide coding region which directs the expressed polypeptide into the secretory pathway of a fungal host cell of choice may be used in the present invention.
Effective signal peptide coding regions for filamentous fungal host cells are the signal peptide coding regions obtained from the genes for Aspergillus oryzae TAKA amylase. Aspergillus niger neutral amylase, Aspergillus niger glucoamylase, Rhizomucor miehei aspartic proteinase, Humicola insolens cellulase, and Humicola lanuginosa lipase.
Useful signal peptides for yeast host cells are obtained from the genes for Saccharomyces cerevisiae alpha-factor and Saccharomyces cerevisiae invertase. Other useful signal peptide coding regions are described by Romanos et al., 1992, supra.
The control sequence may also be a propeptide coding region that codes for an amino acid sequence positioned at the amino terminus of a polypeptide. The resultant polypeptide is known as a proenzyme or propolypeptide (or a zymogen in some cases). A propolypeptide is generally inactive and can be converted to a mature active polypeptide by catalytic or autocatalytic cleavage of the propeptide from the propolypeptide. The propeptide coding region may be obtained from the genes for Saccharomyces cerevisiae alpha-factor Rhizomucor miehei aspartic proteinase, and Myceliophthora thermophila laccase (WO 95/33836).
Where both signal peptide and propeptide regions are present at the amino terminus of a polypeptide, the propeptide region is positioned next to the amino terminus of a polypeptide and the signal peptide region is positioned next to the amino terminus of the propeptide region.
It may also be desirable to add regulatory sequences which allow the regulation of the expression of the polypeptide or the copper-dependent trans-acting transcription factor relative to the growth of the host cell. Examples of regulatory systems are those which cause the expression of the gene to be turned on or off in response to a chemical or physical stimulus, including the presence of a regulatory compound. In yeast, the ADH2 system or GAL1 system may be used. In filamentous fungi, the TAKA alpha-amylase promoter, Aspergillus niger glucoamylase promoter, Aspergillus oryzae glucoamylase promoter, and Fusarium venenatum glucoamylase promoter may be used as regulatory sequences. Other examples of regulatory sequences are those which allow for gene amplification. In eukaryotic systems, these include the dihydrofolate reductase gene which is amplified in the presence of methotrexate, and the metallothionein genes which are amplified with heavy metals. In these cases, the nucleic acid sequence encoding the polypeptide would be operably linked with the regulatory sequence.
Expression VectorsThe present invention also relates to recombinant expression vectors comprising a first polynucleotide comprising a nucleic acid sequence encoding a polypeptide of interest operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter. The various nucleic acid and control sequences described above may be joined together to produce a recombinant expression vector which may include one or more convenient restriction sites to allow for insertion or substitution of the nucleic acid sequence encoding the polypeptide at such sites. Alternatively, the nucleic acid sequence may be expressed by inserting the first polynucleotide and the second polynucleotide into an appropriate vector for expression. In creating the expression vector, the coding sequence is located in the vector so that the coding sequence is operably linked to a copper-inducible promoter, a copper-responsive upstream activation sequence, and one or more appropriate control sequences for expression.
The recombinant expression vector may be any vector (e.g., a plasmid or virus) which can be conveniently subjected to recombinant DNA procedures and can bring about the expression of the nucleic acid sequence. The choice of the vector will typically depend on the compatibility of the vector with the host cell into which the vector is to be introduced. The vectors may be linear or closed circular plasmids.
The vector may be an autonomously replicating vector, i.e., a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid, an extrachromosomal element, a minichromosome, or an artificial chromosome. The vector may contain any means for assuring self-replication. Alternatively, the vector may be one which, when introduced into the host cell, is integrated into the genome and replicated together with the chromosome(s) into which it has been integrated. Furthermore, a single vector or plasmid or two or more vectors or plasmids which together contain the total DNA to be introduced into the genome of the host cell, or a transposon may be used.
The vectors of the present invention preferably contain one or more selectable markers which permit easy selection of transformed cells. A selectable marker is a gene the product of which provides for biocide or viral resistance, resistance to heavy metals, prototrophy to auxotrophs, and the like. Suitable markers for yeast host cells are ADE2, HIS3, LEU2, LYS2, MET3, TRP1, and URA3. Selectable markers for use in a filamentous fungal host cell include, but are not limited to, amdS (acetamidase), argB (ornithine carbamoyltransferase), bar (phosphinothricin acetyltransferase), hygB (hygromycin phosphotransferase), niaD (nitrate reductase), pyrG (orotidine-5′-phosphate decarboxylase), sC (sulfate adenyltransferase), trpC (anthranilate synthase), as well as equivalents thereof. Preferred for use in an Aspergillus cell are the amdS and pyrG genes of Aspergillus nidulans or Aspergillus oryzae and the bar gene of Streptomyces hygroscopicus. Preferred for use in a Fusarium cell is the bar, amdS, pyrG, or hygB gene.
The vectors of the present invention preferably contain an element(s) that permits stable integration of the vector into the host cell's genome or autonomous replication of the vector in the cell independent of the genome.
For integration into the host cell genome, the vector may rely on the polynucleotide's sequence encoding the polypeptide or any other element of the vector for integration into the genome by homologous or nonhomologous recombination. Alternatively, the vector may contain additional nucleotide sequences for directing integration by homologous recombination into the genome of the host cell at a precise location(s) in the chromosome(s). To increase the likelihood of integration at a precise location, the integrational elements should preferably contain a sufficient number of nucleic acids, such as 100 to 10,000 base pairs, preferably 400 to 10,000 base pairs, and most preferably 800 to 10,000 base pairs, which have a high degree of identity to the corresponding target sequence to enhance the probability of homologous recombination. The integrational elements may be any sequence that is homologous with the target sequence in the genome of the host cell. Furthermore, the integrational elements may be non-encoding or encoding nucleotide sequences. On the other hand, the vector may be integrated into the genome of the host cell by non-homologous recombination.
For autonomous replication, the vector may further comprise an origin of replication enabling the vector to replicate autonomously in the host cell. Examples of a plasmid replicator useful in a yeast cell are the 2 micron origin of replication, ARS1, ARS4, the combination of ARS1 and CEN3, and the combination of ARS4 and CEN6. Examples of a plasmid replicator useful in a filamentous fungal cell are AMA1 and ANS1 (Gems et al., 1991, Gene 98:61-67; Cullen et al., 1987, Nucleic Acids Research 15: 9163-9175; WO 00/24883). Isolation of the AMA1 gene and construction of plasmids or vectors comprising the gene can be accomplished according to the methods disclosed in WO 00/24883. The origin of replication may be one having a mutation which makes its functioning temperature-sensitive in the host cell (see, e.g., Ehrlich, 1978, Proceedings of the National Academy of Sciences USA 75: 1433).
More than one copy of a nucleic acid sequence encoding a polypeptide may be inserted into the host cell to increase production of the gene product. An increase in the copy number of the nucleic acid sequence can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selectable marker gene with the nucleic acid sequence where cells containing amplified copies of the selectable marker gene, and thereby additional copies of the nucleic acid sequence, can be selected for by cultivating the cells in the presence of the appropriate selectable agent.
The procedures used to ligate the elements described above to construct the recombinant expression vectors of the present invention are well known to one skilled in the art (see, e.g., Sambrook et al., 1989, supra).
Fungal Host CellsThe present invention also relates to recombinant fungal host cells, comprising a first polynucleotide comprising a nucleic acid sequence encoding a polypeptide of interest operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and further comprising a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor. An expression vector or nucleic acid construct, as described herein, is introduced into a host cell so that the vector or construct is maintained as a chromosomal integrant or as a self-replicating extra-chromosomal vector as described earlier. The term “host cell” encompasses any progeny of a parent cell that is not identical to the parent cell due to mutations that occur during replication. The choice of a host cell will to a large extent depend upon the polynucleotide encoding the polypeptide and its source as well as the polynucleotide encoding the copper-dependent trans-acting transcription factor.
The host cell may be any fungal cell useful in the methods of the present invention. “Fungi” as used herein includes the phyla Ascomycota, Basidiomycota, Chytridiomycota, and Zygomycota (as defined by Hawksworth et al., In, Ainsworth and Bisby's Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge, UK) as well as the Oomycota (as cited in Hawksworth et al., 1995, supra, page 171) and all mitosporic fungi (Hawksworth et al., 1995, supra).
In a preferred aspect, the fungal host cell is a yeast cell. “Yeast” as used herein includes ascosporogenous yeast (Endomycetales), basidiosporogenous yeast, and yeast belonging to the Fungi Imperfecti (Blastomycetes). Since the classification of yeast may change in the future, for the purposes of this invention, yeast shall be defined as described in Biology and Activities of Yeast (Skinner, F. A., Passmore, S. M., and Davenport, R. R., eds, Soc. App. Bacteriol. Symposium Series No: 9, 1980).
In a more preferred aspect, the yeast host cell is a Candida, Hansenula, Kluyveromyces, Pichia, Saccharomyces, Schizosaccharomyces, or Yarrowia cell.
In a most preferred aspect, the yeast host cell is a Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces diastaticus, Saccharomyces douglasii, Saccharomyces kluyveri, Saccharomyces norbensis or Saccharomyces oviformis cell. In another most preferred aspect, the yeast host cell is a Kluyveromyces lactis cell. In another most preferred aspect, the yeast host cell is a Yarrowia lipolytica cell.
In an even most preferred aspect, the yeast host cell is Saccharomyces carlsbergensis cerevisiae JG169 (MAT-α, ura3-52, leu2-3, pep4-1137, his3Δ2, prb1::leu2, Δpre1::his3) (U.S. Pat. No. 5,770,406).
In another preferred aspect, the fungal host cell is a filamentous fungal cell. “Filamentous fungi” include all filamentous forms of the subdivision Eumycota and Oomycota (as defined by Hawksworth et al., 1995, supra). The filamentous fungi are characterized by a mycelial wall composed of chitin, cellulose, glucan, chitosan, mannan, and other complex polysaccharides. Vegetative growth is by hyphal elongation and carbon catabolism is obligately aerobic. In contrast, vegetative growth by yeasts such as Saccharomyces cerevisiae is by budding of a unicellular thallus and carbon catabolism may be fermentative.
In a more preferred aspect, the filamentous fungal host cell is an Acremonium, Aspergillus, Aureobasidium, Bjerkandera, Ceriporiopsis, Chrysosporium, Coprinus, Coriolus, Cryptococcus, Filibasidium, Fusarium, Humicola, Magnaporthe, Mucor, Myceliophthora, Neocallimastix, Neurospora, Paecilomyces, Penicillium, Phanerochaete, Phlebia, Piromyces, Pleurotus, Schizophyllum, Talaromyces, Thermoascus, Thielavia, Tolypocladium, Trametes, or Trichoderma cell.
In a most preferred aspect, the filamentous fungal host cell is an Aspergillus awamori, Aspergillus fumigatus, Aspergillus foetidus, Aspergillus japonicus, Aspergillus nidulans, Aspergillus niger or Aspergillus oryzae cell. In another most preferred aspect, the filamentous fungal host cell is a Fusarium bactridioides, Fusarium cerealis, Fusarium crookwellense, Fusarium culmorum, Fusarium graminearum, Fusarium graminum, Fusarium heterosporum, Fusarium negundi, Fusarium oxysporum, Fusarium reticulatum, Fusarium roseum, Fusarium sambucinum, Fusarium sarcochroum, Fusarium sporotrichioides, Fusarium sulphureum, Fusarium torulosum, Fusarium trichotheciodes, or Fusarium venenatum cell. In another most preferred aspect, the filamentous fungal host cell is a Bjerkandera adusta, Ceriporiopsis aneirina, Ceriporiopsis aneirina, Ceriporiopsis caregiea, Ceriporiopsis gilvescens, Ceriporiopsis pannocinta, Ceriporiopsis rivulosa, Ceriporiopsis subrufa, Ceriporiopsis subvermispora, Chrysosporium keratinophilum, Chrysosporium lucknowense, Chrysosporium tropicum, Chrysosporium merdarium, Chrysosporium inops, Chrysosporium pannicola, Chrysosporium queenslandicum, Chrysosporium zonatum, Coprinus cinereus, Coriolus hirsutus, Humicola insolens, Humicola lanuginosa, Mucor miehei, Myceliophthora thermophila, Neurospora crassa, Penicillium purpurogenum, Phanerochaete chrysosporium, Phlebia radiata, Pleurotus eryngii, Thielavia terrestris, Trametes villosa, Trametes versicolor, Trichoderma harzianum, Trichoderma koningii, Trichoderma longibrachiatum, Trichoderma reesei or Trichoderma viride cell.
Fungal cells may be transformed by a process involving protoplast formation, transformation of the protoplasts, and regeneration of the cell wall in a manner known per se. Suitable procedures for transformation of Aspergillus host cells are described in EP 238 023 and Yelton et al., 1984, Proceedings of the National Academy of Sciences USA 81: 1470-1474. Suitable procedures for transformation of Trichoderma reesei host cells is described in Penttila et al., 1987, Gene 61: 155-164, and Gruber et al., 1990, Curr Genet. 18(1):71-6. Suitable methods for transforming Fusarium species are described by Malardier et al., 1989, Gene 78: 147-156 and WO 96/00787. Yeast may be transformed using the procedures described by Becker and Guarente, In Abelson, J. N. and Simon, M. I., editors, Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, Volume 194, pp 182-187, Academic Press, Inc., New York; Ito et al., 1983, Journal of Bacteriology 153: 163; and Hinnen et al., 1978, Proceedings of the National Academy of Sciences USA 75: 1920.
The present invention is further described by the following examples which should not be construed as limiting the scope of the invention.
EXAMPLESChemicals used as buffers and substrates were commercial products of at least reagent grade.
DNA SequencingDNA sequencing was performed using an Applied Biosystems Model 3130X Genetic Analyzer (Applied Biosystems, Foster City, Calif., USA) using dye terminator chemistry (Giesecke et al., 1992, Journal of Virol. Methods 38: 47-60). Sequences were assembled using phred/phrap/consed (University of Washington, Seattle, Wash., USA) with sequence specific primers.
StrainSaccharomyces cerevisiae JG169 (MAT-α, ura3-52, leu2-3, pep4-1137, his3Δ2, prb1::leu2, Δpre1::his3) (U.S. Pat. No. 5,770,406) was used as the host strain in the Examples herein.
Culture MediaYPD medium was composed per liter of 10 g of yeast extract, 20 g of Bacto peptone, and 2% glucose.
CUP minus ura medium (pH 7.0) (original medium) was composed per liter of 1 ml of 100 mM CuSO4.5H2O, 1.7 g of yeast nitrogen base (YNB) without amino acids and ammonium sulfate (BIO101, Carlsbad, Calif., USA), 0.8 g of CSM-ura with 40 mg of adenine (BIO101, Carlsbad, Calif., USA), 5 g of Casamino acids (Becton, Dickenson and Company, Sparks, Md., USA), 100 ml of 50% glucose, 50 ml of 0.5 M K2HPO4, and 1 ml of 100 mg/ml ampicillin.
Yeast ura minus optimized medium (optimal medium) was composed per liter of 1 ml of 100 mM CuSO4.5H2O, 6.7 g of yeast nitrogen base (YNB) with ammonium sulfate, 0.8 g of CSM-ura with 40 mg of adenine, 5.9 g of succinic acid (Sigma Chemical Co., St. Louis, Mo., USA), 20 g of galactose, 10 g of glucose, and 1 ml of 100 mg/ml ampicillin.
Yeast ura minus selection medium was composed per liter of 6.7 g of yeast nitrogen base (YNB) with ammonium sulfate, 5 g of Casamino acids, 100 ml of 0.5 M succinic acid pH 5, 40 ml of 50% glucose, and 2 ml of 10 mg/ml chloramphenicol.
Yeast ura minus selection plates were composed of yeast ura minus selection medium supplemented with 20 g of Noble agar per liter.
SC ura minus medium was composed per liter of 7.5 g of yeast nitrogen base without amino acids (Fluka, Buchs, Switzerland), 11.3 g of succinic acid, 6.8 g of sodium hydroxide, 5.6 g of Casamino acids, and 0.1 g of L-tryptophan, and 100 ml of a sterile solution of 50% fructose and 400 μl of a sterile solution of 250 mg/ml of ampicillin, both added after autoclaving.
SC ura minus plates were composed of SC ura minus medium, except 100 ml of sterile 20% fructose is used, and 20 g of agar (Sigma Chemical Co., St. Louis, Mo., USA).
SDMUA medium was composed per liter of 1.7 g of yeast nitrogen base without amino acids, 5.0 g of Casamino acids, 0.8 g of CMS-Ura with 40 mg/l ADE (MP Biomedicals, Irvine, Calif., USA), 10 ml of 10 mM CuSO4.5H2O, and 10 ml of 1 M K2HPO4, and 100 ml of sterile 50% fructose and 400 μl of sterile 250 mg/ml of ampicillin, both added after autoclaving.
LB medium was composed per liter of 10 g of tryptone, 5 g of yeast extract, and 5 g of sodium chloride
LB plates were composed of LB medium and 15 g of Bacto agar per liter.
SOC medium was composed of 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, and 10 mM MgSO4, sterilized by autoclaving and then filter-sterilized glucose was added to 20 mM.
2×YT plates were composed per liter of 16 g of tryptone, 10 g of yeast extract, 5 g of NaCl, and 15 g of bacto agar.
Example 1 PCR Amplification of a Copper-Inducible Promoter (CUP1 Promoter)PCR primers 997247 and 997248, shown below, were designed to amplify the Saccharomyces cerevisiae copper-inducible promoter (CUP1 promoter) from plasmid pCu426 (Labbe and Thiele, 1999, Methods in Enzymology 306: 145-153). Restriction enzyme sites, Age I and Eco RI, were incorporated into the primer design for cloning into the Saccharomyces cerevisiae expression plasmid pMB1537 (see Example 2).
The CUP promoter fragment was amplified by PCR using an EXPAND® High Fidelity PCR System (Roche, Indianapolis, Ind., USA). The PCR amplification reaction mixture contained approximately 50 ng of pCu426 plasmid DNA, 1 μl of primer 997247 (50 pmol/μl), 1 μl of primer 997248 (50 pmol/μl), 5 μl of 10×PCR buffer (Roche, Indianapolis, Ind., USA) with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl (3.5 U/μl) of DNA polymerase mix (Roche, Indianapolis, Ind., USA). An EPPENDORF®, MASTERCYCLER® 5333 (Eppendorf, Westbury, N.Y., USA) was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes, 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds plus a 5 second elongation at each successive cycle; 1 cycle at 72° C. for 7 minutes; and a 10° C. hold.
A PCR product of 246 bp was purified by 1.5% agarose gel electrophoresis using TAE buffer (4.84 g of Tris Base, 1.14 ml of glacial acetic acid, and 2 ml of 0.5 M EDTA pH 8.0 per liter) and further purified using a QIAQUICK® Gel Extraction Kit (QIAGEN Inc., Valencia, Calif., USA). The 246 bp PCR product was ligated with pCR2.1-TOPO® (Invitrogen Corporation, Carlsbad, Calif., USA) according to the manufacturer's instructions. After the incubation, 2 μl of the mixture was used to transform ONE SHOT® TOP10 chemically competent E. coli cells (Invitrogen Corporation, Carlsbad, Calif. USA). A 2 μl volume of the ligation mixture was added to the E. coli cells and incubated on ice for 5 minutes. Subsequently, the cells were heat shocked for 30 seconds at 42° C., and then placed on ice for 2 minutes. A 250 μl volume of SOC medium was added to the cells and the mixture was incubated for 1 hour at 37° C. and 250 rpm. After the incubation the colonies were spread on 2×YT plates supplemented with 100 μg of ampicillin per ml and incubated at 37° C. overnight for selection of the plasmid. Eight colonies that grew on the plates were picked with sterile toothpicks and grown overnight at 37° C., 250 rpm in a 15 ml FALCON® tube containing 3 ml of LB medium supplemented with 100 μg of ampicillin per ml. The plasmids were isolated using a BioRobot 9600 (QIAGEN Inc., Valencia, Calif., USA).
Four μl volumes of the resulting plasmid minipreps were digested with Eco RI. The digestion reactions were analyzed by agarose gel chromatography and UV analysis as previously described for the PCR reaction. Isolated plasmids containing an insert were sequenced using 1 μl of plasmid template, 1.6 ng of M13 primer (forward or reverse) (MWG Biotech, High Point, N.C., USA), and water to 6 μl. The resulting plasmid with the correct sequence was designated pBM128a (
Expression vector pMB1537 contains the yeast TPI promoter driving expression of a wild-type gene encoding a Thermomyces lanuginosus lipase (SEQ ID NO: 27 is the DNA sequence and SEQ ID NO: 28 is the deduced amino acid sequence; Accession Number O59952), the CYC1 terminator, and the URA3 gene as a selectable marker.
Yeast expression plasmid pSTED226 (WO 05/045018) was PCR amplified using an EXPAND® Long Template PCR System (Roche, Germany) with pSTED226 as template and the following two primers.
The PCR amplification reaction mixture contained approximately 50 ng of pSTED226 plasmid DNA, 1 μl of primer 319137 (50 pmol/μl), 1 μl of primer 19138 (50 pmol/μl), 5 μl of 10×PCR buffer (Roche, Indianapolis, Ind., USA) with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl (3.5 U/μl) of DNA polymerase mix (Roche, Indianapolis, Ind., USA). A PTC Peltier Thermal Cycler (Bio-Rad Laboratories, Hercules, Calif., USA) was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes; 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds plus a 5 second elongation at each successive cycle; 1 cycle at 72° C. for 7 minutes; and a 10° C. hold. After termination of the PCR procedure a PCR fragment of 5826 bp was purified and eluted with a GFX® PCR DNA and Gel Band Purification Kit according to the manufacturer's instructions (Amersham Biosciences, United Kingdom).
A gene fragment containing the Thermomyces lanuginosus wild-type lipase gene was PCR amplified using an EXPAND® High Fidelity PCR System with pENI1298 (WO 00/24883) as template and the following two primers:
The PCR amplification reaction mixture contained approximately 50 ng of pENI1298 plasmid DNA, 1 μl of primer 349699 (50 pmol/μl), 1 μl of primer 353031 (50 pmol/μl), 5 μl of 10×PCR buffer (Roche, Indianapolis, Ind., USA) with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl (3.5 U/μl) of DNA polymerase mix (Roche, Indianapolis, Ind., USA). A PTC Pettier Thermal Cycler was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes; 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds plus a 5 second elongation at each successive cycle; 1 cycle at 72° C. for 7 minutes; and a 10° C. hold. After termination of the PCR procedure a PCR fragment of 927 bp was purified and eluted with a GFX® PCR DNA and Gel Band Purification Kit according to the manufacturer's instructions.
The resulting two fragments, 5826 bp and 927 bp were transformed into Saccharomyces cerevisiae JG169 by electroporation using a GENE PULSER® and Pulse Controller (Bio-Rad, Hercules, Calif., USA) at 1.5 kvolts with a 2 mm gap cuvette according to the manufacturer's procedure. Transformation reactions contained 100 ng of PCR amplified vector DNA mixed with 100 ng of the PCR product containing the lipase gene. Transformation reactions were plated onto yeast ura minus selection plates and incubated for 5 days at 30° C.
One yeast clone from the procedure above was restreaked on SC ura minus plates and one single yeast colony was inoculated into 10 ml of SC ura minus medium in a 50 ml shake flask and incubated overnight at 30° C., 250 rpm. Two ml of culture broth was used in a plasmid preparation using a QIAPREP® Spin Miniprep Kit (QIAGEN Inc., Germany) for yeast plasmid preparation. The plasmid was later sequenced and the expected DNA sequence was verified. The plasmid was designated pMB1537 (
Plasmid pBM128a was digested with Age I and Eco RI, and plasmid pMB1537 was digested with Eco RI and Nde I and the fragments, 265 bp and 661 bp, respectively, were purified by 1.8% and 0.7% agarose get electrophoresis using TAE buffer in conjunction with a QIAQUICK® Gel Extraction Kit. To create the vector fragment, pMB1537 was digested with Age I and Nde I. The resulting 5148 bp fragment was purified by 0.7% agarose gel electrophoresis using TAE buffer in conjunction with a QIAQUICK® Gel Extraction Kit.
All three fragments were subsequently ligated using a Rapid DNA Ligation Kit (Roche Diagnostics Corporation, Indianapolis, Ind., USA). Two μl of the reaction were used to transform E. coli XL10-GOLD® Ultracompetent Cells (Stratagene, La Jolla, Calif., USA) according to manufacturer's instructions. Plasmid DNA was prepared from E. coli transformants using a BioRobot 9600. Isolated plasmids containing an insert were sequenced using 1 μl of plasmid template, 1.6 ng of M13 primer (forward or reverse), and water to 6 μl. The resulting plasmid identified as having the correct sequence was designated pBM126a (
Plasmid pMB1539 was constructed to contain a gene encoding a Thermomyces lanuginosus lipase variant (SEQ ID NO: 33 is the DNA sequence and SEQ ID NO: 34 is the deduced amino acid sequence) under control of the TPI promoter.
A gene fragment containing the Thermomyces lanuginosus lipase variant gene was prepared by PCR using pENi1298 (WO 00/24883) containing the Thermomyces lanuginosus wild-type lipase gene (SEQ ID NO: 27) as template using an EXPAND® High Fidelity PCR System, and primers 349699 and 353031, shown below.
The PCR amplification reaction mixture contained approximately 50 ng of pENi1298 plasmid DNA, 1 μl of primer 349699 (50 pmol/μl), 1 μl of primer 353031 (50 pmol/μl), 5 μl of 10×PCR buffer (Roche, Indianapolis, Ind., USA) with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl (3.5 U/μl) of DNA polymerase mix (Roche, Indianapolis, Ind., USA). A PTC Pettier Thermal Cycler was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes; 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds plus a 5 second elongation at each successive cycle, 1 cycle at 72° C. for 7 minutes; and a 10° C. hold.
After PCR amplification, a DNA fragment of 993 bp was purified using a GFX® PCR DNA and Gel Band Purification Kit. The resulting fragment (100 ng) was mixed with the pSTED226 vector fragment (100 ng) described in Example 2 and transformed into electrocompetent Saccharomyces cerevisiae JG169 cells by electroporation using a GENE PULSER® and Pulse Controller at 1.5 kvolts with a 2 mm gap cuvette according to the manufacturer's procedure. Transformed cells were then plated onto yeast ura minus selection plates and incubated for 5 days at 30° C.
One yeast clone from the procedure above was restreaked on SC ura minus plates and one single yeast colony was used to inoculate 10 ml of SC ura minus medium in a 50 ml shake flask and incubated overnight at 30° C., 250 rpm. From this culture 2 ml of culture broth were used in a plasmid preparation using a QIAPREP® Spin Miniprep Kit for yeast plasmid preparation. The plasmid was later sequenced and the expected DNA sequence was verified. The plasmid was designated pMB1539 (
Construction of a Thermomyces lanuginosus lipase variant expression vector utilizing the CUP1 promoter was accomplished by swapping the Thermomyces lanuginosus wild-type lipase gene in pBM126a (containing the Thermomyces lanuginosus wild-type lipase gene under control of CUP1 promoter) with the Thermomyces lanuginosus lipase variant gene from pMB1539. First, both pBM126a and pMB1539 were digested with Hind III and Mlu I, and a 5 kb fragment from pBM126a and a 1.1 kb fragment from pMB1539 were gel-purified using a QIAQUICK® Gel Extraction Kit. Both fragments were subsequently ligated using a Rapid DNA Ligation Kit in molar ratios of vector:insert at 1:2, 1:3, and 1:4 with the vector amount set at 50 ng. The resulting plasmid, designated pJLin168 (
The following primers were designed to remove the last five codons encoding amino acids SPIRR from the propeptide sequence of the Thermomyces lanuginosus variant lipase in pJLin168 using a QUIKCHANGE® Site-Directed Mutagenesis Kit (Stratagene, La Jolla, Calif., USA):
One hundred picomoles of each primer were used in a PCR reaction containing 73 ng of pJLin168, 1X QUIKCHANGE® reaction buffer (Stratagene, La Jolla, Calif., USA), 4 μl of QUIKSOLUTION® (Stratagene, La Jolla, Calif., USA), 1 μl of XL dNTP mix (Stratagene, La Jolla, Calif. USA), and 1 μl of 2.5 U/μl PfuUltra™ DNA polymerase (Stratagene, La Jolla, Calif., USA), in a final volume of 50 μl. An EPPENDORF® MASTERCYCLER® was programmed for one cycle at 95° C. for 1 minute; 18 cycles each at 95° C. for 50 seconds, 60° C. for 50 seconds, and 68° C. for 6 minutes, and a 10° C. hold. One microliter of Dpn I was added directly to the amplification reaction and incubated at 37° C. for 1 hour. A 2 μl volume of the Dpn I digestion reaction was used to transform E. coli XL10-GOLD® Ultracompetent Cells (Stratagene, La Jolla, Calif., USA) according to the manufacturer's instructions. One of the clones without 15 bp corresponding to the SPIRR-coding region was confirmed by DNA sequencing and was designated pBM142c (
To avoid additional mutations being generated in pBM142c, the 5′ region of Thermomyces lanuginosus variant lipase gene from pBM142c was cloned back into pJLin168. Plasmid pBM142c was digested with Hind III and Nde I, and the 0.6 kb fragment was purified by 1.5% agarose gel electrophoresis using TAE buffer in conjunction with a QIAQUICK® Gel Extraction Kit. Plasmid pJLin168 was digested with Hind III and Nde I, and the resulting 5.5 kb fragment was purified by 0.7% agarose gel electrophoresis using TAE buffer in conjunction with a QIAQUICK® Gel Extraction Kit. The two fragments were subsequently ligated using a Rapid DNA Ligation Kit. The resulting expression plasmid, designated pBM143b (
Plasmid pMB1537 containing the Thermomyces lanuginosus wild-type lipase gene was used to construct a random mutagenized library of the Thermomyces lanuginosus lipase signal peptide. The random mutagenized PCR fragment of the signal peptide coding sequence and flanking DNA regions were amplified by PCR using an EXPAND® High Fidelity PCR System and the primers (DNA-Technology, Aarhus, Denmark) below.
where N at positions 41, 50, 51, 60, 64, 66, 68, 70, 71, 72, 74, 75, 77, 80, 82, 83, and 87 of SEQ ID NO: 40 is 99% A and 1% G, C or T;
N at positions 40, 46, 47, 52, 53, 56, 62, 65, 67, 73, 78, 84, 85, 86, and 88 of SEQ ID NO: 40 is 99% G and 1% A, C, or T;
N at positions 42, 43, 45, 48, 49, 54, 55, 58, 59, 61, 63, 69, 76, 79, 81, 89, 91, and 92 of SEQ ID NO: 40 is 99% C and 1% A, G, or T; and
N at positions 44, 57, 90, and 93 of SEQ ID NO: 40 is 99% T and 1% A, C, or G.
The primer introducing the diversity was designed after the following rules: The wild-type base at the randomized positions was always present at 99% and the other three bases were present at 1% and all three were equally represented.
The mutagenized fragment of the signal peptide coding sequence was amplified by PCR using an EXPAND® High Fidelity PCR System. The PCR amplification reaction mixture contained approximately 50 ng of pMB1537, 1 μl of primer 309787 (50 pmol/μl), 1 μl of primer 373172 (50 pmol/μl), 5 μl of 10×PCR buffer (Roche, Indianapolis, Ind., USA) with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl (3.5 U/μl) of DNA polymerase mix (Roche, Indianapolis, Ind., USA), A PTC Peltier Thermal Cycler was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes; 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 15 seconds plus a 5 second elongation at each successive cycle; 1 cycle at 72° C. for 7 minutes; and a 10° C. hold.
A gene fragment of the Thermomyces lanuginosus wild-type lipase gene was prepared by PCR using pMB1537 as template in a PCR reaction using an EXPAND® High Fidelity PCR System. The primers used in the PCR were primers 309787 and 373172 described above.
After PCR amplification, a PCR fragment of 600 bp was purified using a GFX® PCR DNA and Gel Band Purification Kit according to the manufacturer's protocol and eluted in 50 μl of 10 mM Tris-HCl pH 8.0.
Plasmid pMB1537 was linearized by digestion with Sac I at a DNA position within the signal peptide coding sequence. The linearized vector was used as the recipient DNA in a transformation of Saccharomyces cerevisiae JG169 using a PCR fragment of the signal peptide coding sequence with flanking DNA regions (100% homologous to the recipient DNA of the recipient plasmid) as the donor DNA.
Specifically, approximately 3 μg of Sac I digested pMB1537 together with approximately 1 μg of the 600 bp PCR fragment were electroporated into 100 μl of electrocompetent Saccharomyces cerevisiae JG169 cells using a GENE PULSER® and Pulse Controller at 1.5 kvolts with a 2 mm gap cuvette. After electroporation the transformed cells were supplied with 1 ml of 1 M sorbitol, and incubated for 1 hour at 30° C. after which 1.1 ml were plated onto SC ura minus plates supplemented with 100 μg of ampicillin per ml.
A total of 8400 colonies from the SC ura minus plates supplemented with 100 μg of ampicillin per ml were picked and transferred to 96-well polystyrene microwell plates, applying the picked clones to the wells in rows B-H and columns 1-12 leaving row A free, which was inoculated with the wild-type plasmid construct in Saccharomyces cerevisiae JG169 as the wild-type reference. All wells contained SD Medium-URA with 40 mg of adenine added per liter (called SDMUA) (following recommendations from the manufacturer, Qbiogene, Inc., BIO 101® System, supplied by AH Diagnostics, Aarhus, Denmark). The plates were incubated at 30° C. and 250 rpm for 5 days. After 5 days the plates were kept at 4° C. before measuring lipase activity using a p-nitrophenyl valerate assay described below.
Lipase activities of culture supernatants were measured using p-nitrophenyl valerate as a substrate in the following assay. Culture supernatants were diluted in 50 mM Tris pH 7, 10 mM CaCl2, 0.4% Triton X-100 buffer (dilution buffer). A LIPOLASE™ standard (Novozymes A/S, Bagsværd, Denmark) was diluted using two-fold steps starting with a 1.0 LU/ml concentration and ending with a 0.125 LU/ml concentration in the sample buffer. In polystyrene microwell plates, 10 μl of supernatant were mixed with 90 μl of the dilution buffer. One hundred microliters of a p-nitrophenyl valerate substrate solution (117 μl of p-nitrophenyl valerate dissolved in 10 ml of isopropanol) was added to each well, briefly mixed, and then the absorbance at 405 nm was measured for 3 minutes every 12 seconds. The assay data was evaluated to identify all samples having higher activity than the pMB1539 construct in Saccharomyces cerevisiae JG169 (in the A-row wells).
All clones with higher activity than the reference were collected as positive hits, which were reanalyzed in the same set-up and all clones still having higher activity than the reference were used as inoculation material with fresh SDMUA medium in microwell plates. The A-row was again used for the reference strain. The plates were incubated as above, and analyzed as described above.
All clones with higher activity than the reference were removed from their wells and restreaked on SC-agar plates. Single colonies of all clones were collected for regrowth in microwell plates in 200 μl of SDMUA medium and 50 ml tubes containing 10 ml of SDMUA medium and incubated at 3000 for 5 days after which yields were compared to that of the reference strain using the p-nitrophenyl valerate assay described above.
Each clone was grown in three adjacent microwells and 3 individual 60 ml tubes. Mean values of the three growth experiments were used for the comparison of activity levels.
Finally the clones with the highest lipase activity in both microwell plates and 50 ml tubes were inoculated in shake flasks (250 ml conical baffled shake flasks with two baffles) containing 10 ml of SDMUA medium and incubated at 250 rpm for 5 days at 30° C. Supernatants were assayed for lipase activity using the p-nitrophenyl valerate assay described above. Clones with the highest lipase activity were DNA sequenced.
The clone showing the highest activity was designated MB1665, which had a R2K substitution in the signal peptide of the lipase (second codon of the signal peptide was altered from AGG to AAG).
By using the same principle as described in Example 4, DNA encoding this signal peptide was transferred to the pMB1539 construct encoding the Thermomyces lanuginosus lipase variant. In this case the smaller PCR fragment was made using the same procedure as described in Example 4. However, the larger fragment was made also according to Example 4 but using plasmid DNA from MB1539 as the template. GAP-repair and transformation of the Saccharomyces cerevisiae JG169 was performed as described above. This cloning resulted in a clone with higher expression of the Thermomyces lanuginosus lipase variant. This clone was designated Saccharomyces cerevisiae MB1681.
Saccharomyces cerevisiae MB1681 cell material from a SC-agar plate (grown 5 days at 30° C.) was used to inoculate 10 ml of SC ura minus medium in a 50 ml shake flask and incubated overnight at 30° C., 250 rpm. From this culture 2 ml of culture broth was used in a plasmid preparation using a QIAPREP® Spin Miniprep Kit for yeast plasmid preparation The purified plasmid was transformed into E. coli Top10F′ (Invitrogen, Carlsbad, Calif., USA) according to manufacturer's instructions. Transformed E. coli cells were plated onto LB plates supplemented with 100 μg of ampicillin per ml. A single colony was isolated, restreaked, inoculated into LB medium, and incubated overnight at 30° C. One ml of the overnight culture was used for plasmid preparation using a QIAPREP® Spin Miniprep Kit. Finally, the isolated plasmid was used as template for DNA sequencing, verifying the sequence of the variant signal sequence (SEQ ID NO: 41) and the Thermomyces lanuginosus lipase variant coding region (SEQ ID NO: 33 with the deduced amino acid sequence of SEQ ID NO: 34). The resulting plasmid was designated pMB1682 (
Plasmid pJLin195 was constructed to contain the Thermomyces lanuginosus lipase variant (with signal sequence containing a R2K change and without SPIRR) expression vector utilizing the Saccharomyces cerevisiae CUP1 promoter.
The Hind III-Nde I fragment of pMB1682 was cloned into pBM143b digested with Hind III and Nde I, replacing the coding sequence of the second amino acid Arg (AGG) with the coding sequence of Lys (AAG). Both pMB1682 and pBM143b were digested with Hind III and Nde I, and a 1 kb fragment from pMB1682 and a 5 kb fragment from pBM143b were gel extracted with a QIAQUICK® Gel Extraction column. The fragments were ligated together in a molar ratio of vector to insert at 1:2, 1:1, and 3:1 with a vector amount of 50 ng using a Rapid DNA Ligation Kit according to the manufacturer's instructions. The resulting plasmid, confirmed by DNA sequencing, was designated pJLin195 (
The following primers were used to generate a PCR fragment for constructing an expression vector containing four Saccharomyces cerevisiae upstream activating sequences (UAS):
The fragment was amplified by PCR using an EXPAND® High Fidelity PCR System. The PCR mixture contained 0.5 μl of approximately 25 ng of pBM143b DNA, 1 μl of primer 999003 (50 pmol/μl), 1 μl of primer 999005 (50 pmol/μl), 5 μl of 10×PCR buffer with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl of DNA polymerase mix (3.5 U/μl). An EPPENDORF® MASTERCYCLER® was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes; 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 30 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 30 seconds plus 5 second elongation at each successive cycle; 1 cycle at 72° C. for 7 minutes; and a 10° C. hold.
The resulting 147 bp PCR fragment was purified by 1.8% agarose gel electrophoresis using TAE buffer in conjunction with a QIAQUICK® Gel Extraction Kit and the 147 bp PCR product was ligated with pCR2.1-TOPO® according to the manufacturer's instructions. A 1 μl volume of fresh PCR product, 3 μl of double-distilled water, and 1 μl of the TOPO® cloning vector were mixed with a pipette and incubated at room temperature for 5 minutes.
After the incubation, 2 μl of the mixture was used to transform ONESHOT® TOPIC chemically competent E. coli cells. A 2 μl volume of the ligation mixture was added to the E. coli cells and incubated on ice for 5 minutes. Subsequently, the cells were heat shocked for 30 seconds at 42° C., and then placed on ice for 2 minutes. A 250 μl volume of SOC medium was added to the cells and the mixture was incubated for 1 hour at 37° C. and 250 rpm. After the incubation the colonies were spread on 2×YT plates supplemented with 100 μg of ampicillin per ml and incubated at 37° C. overnight for selection of the plasmid. Eight colonies that grew on the plates were picked with sterile toothpicks and grown overnight at 37° C., 250 rpm in a 15 ml FALCON® tube containing 3 ml of LB medium supplemented with 100 μg of ampicillin per ml. The plasmids were isolated using a BioRobot 9600.
Four μl volumes of the resulting plasmid minipreps were digested with Eco RI. The digestion reactions were analyzed by agarose gel chromatography as previously described for the PCR reaction. Isolated plasmids containing an insert were sequenced using 1 μl of plasmid template, 1.6 ng of M13 primer (forward or reverse), and water to 6 μl. The resulting plasmid was confirmed by DNA sequencing, and designated pBM163a (
To create the final expression construct containing four UAS sequences, pBM163a was digested with Sph I and Age I, and plasmid pJLin168 with Age I and Hind III. The 132 bp Sph I-Age I and 340 bp Age I-Hind III fragments were cloned into the Thermomyces lanuginosus variant lipase expression vector pBM143b, which had been previously digested with Sph I and Hind III. The resulting plasmid was designated pBM165a (
The following PCR primers were designed to amplify the ACE1 gene from genomic DNA of Saccharomyces cerevisiae strain S288C (ATCC 20458). A Bsp HI restriction site was incorporated for cloning into the expression plasmids pBM143b and pJLin195.
The ACE1 gene fragment was amplified by PCR using an EXPAND® High Fidelity PCR System. Genomic DNA was isolated from Saccharomyces cerevisiae strain S288C using a YEASTAR™ Genomic DNA Kit (ZYMO Research, Orange, Calif., USA) according to the manufacturer's instructions. The PCR reaction contained 0.1 μg of Saccharomyces cerevisae S288C genomic DNA, 1 μl of primer 999262 (50 pmol/μl), 1 μl of primer 999263 (50 pmol/μl), 5 μl of 10×PCR buffer with 15 mM MgCl2, 1 μl of dNTP mix (10 mM each), 40.25 μl of water, and 0.75 μl (3.5 U/μl) of DNA polymerase mix in a final volume of 50 μl. An EPPENDORF® MASTERCYCLER® was used to amplify the fragment programmed for 1 cycle at 94° C. for 2 minutes, 10 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 1 minute 45 seconds; 15 cycles each at 94° C. for 15 seconds, 55° C. for 30 seconds, and 72° C. for 1 minute 45 seconds plus a 5 seconds elongation at each successive cycle; 1 cycle at 72° C. for 7 minutes; and a 10° C. hold.
The resulting 1589 bp PCR fragment was purified by 1.8% agarose gel electrophoresis using TAE buffer in conjunction with a QIAQUICK® Gel Extraction Kit. The 1589 bp PCR product was ligated with pCR2.1-TOPO® according to the manufacturer's instructions. The resulting plasmid, designated pBM168a (
Plasmid pBM168a digested with Bsp HI and the ACE1 gene segment (1583 bp) were cloned into expression vectors pBM143b, pJLin195, and pBM165a, which had been digested with the same enzyme. The fragments were gel extracted with a QIAQUICK® Gel Extraction column. The fragments were ligated together in a molar ratio of vector to insert of 1:2, 1:1, and 3:1 with a vector amount of 50 ng using a Rapid DNA Ligation Kit following the manufacturer's instructions. The resulting plasmids were designated pBM169a (
Plasmids pBM143b, pJLin195, pBM165a, pBM169a, pBM170a, and pBM171a were each transformed into Saccharomyces cerevisiae JG169 cells using a YEASTMAKER™ Yeast Transformation System (Clonetech, Palo Alto, Calif., USA) according to the manufacturer's instructions. Briefly, one colony of Saccharomyces cerevisiae JG169 was used to inoculate 50 ml of YPD medium and incubated at 30° C. overnight on an orbital shaker (250 rpm).
When the cells reached an absorbance of 0.4 to 0.5 at 600 nm, the cells were centrifuged at 700×g for 5 minutes, the supernatant was discarded, and the pellet was resuspended in 30 ml of deionized water. After centrifugation at 700×g for 5 minutes in a Sorvall RT 6000D centrifuge the cell pellet was resuspended in 1.5 ml of 1.1×TE/lithium acetate solution (110 mM lithium acetate, 11 mM Tris, pH 8, 1.1 mM EDTA). After centrifugation at 12,000×g in a microcentrifuge for 15 seconds, the cell pellet was resuspended in 600 μl of 1.1×TE/lithium acetate solution. After addition of approximately 0.5 μg of pBM143b, pJLin195, pBM165a, pBM170a, or pBM171a, 250 μl of PEG/lithium acetate solution (40% PEG 4000, 0.1 M lithium acetate, 10 mM Tris-HCl, pH 8, 1 mM EDTA), and 5 μl of 10 mg/ml denatured Herring Testes Carrier DNA to 50 μl of competent cells, the mixtures were shaken at 550 rpm at 30° C. for 30 minutes, and cells were mixed by inversion every 10 minutes. A total volume of 20 μl of DMSO was added to each transformation mixture, and incubated at 42° C. for 15 minutes, and the mixture was inverted every 5 minutes. The transformation mixtures were centrifuged for 15 seconds at 12,000×g in a microcentrifuge, and the cells were resuspended in 1 ml of YPD PLUS™ Liquid Medium (YEASTMAKER™ Yeast Transformation System, Clonetech, Palo Alto, Calif., USA) and shaken at 550 rpm and 30° C. for 90 minutes. After centrifugation, the cells were washed with 1 ml of 0.9% NaCl solution and resuspended in 1 ml of yeast ura minus selection medium in the presence of 15% glycerol. Fifty microliters of each transformation reaction were plated in duplicate onto yeast ura minus selection plates and incubated at 30° C. until colonies appeared.
Saccharomyces cerevisiae JG169 transformants containing pBM143b, pJLin195, pBM165a, pBM169a, pBM170a, or pBM171a were used to inoculate 180 μl of ura minus selection medium in 96-well plates and were incubated at 30° C., 250 rpm overnight. The overnight cultures were then diluted 100-fold in 180 μl of copper-inducing “original” or “optimal” medium and grown for five days at 30° C.
Lipase activities of culture supernatants were measured using p-nitrophenyl butyrate (pNB) as a substrate in the following assay: Culture supernatants were initially diluted 1/15-fold in 0.1 M MOPS, 4 mM CaCl2, 0.01% Triton X-100 buffer, pH 7.5 (sample buffer), followed by serial dilution from 0-fold to 1/3-fold to 1/9-fold of the diluted sample. A LIPOLASE™ standard (Novozymes A/S, Bagsværd, Denmark) was diluted using two-fold steps starting with a 1.0 LU/ml concentration and ending with a 0.125 LU/ml concentration in the sample buffer. A total of 20 μl of each dilution, including the standard, were transferred to a 96-well flat bottom plate. Two hundred microliters of a p-nitrophenyl butyrate substrate solution (the ratio of p-nitrophenyl butyrate:DMSO:0.1M MOPS pH 7.5 was 1:99:400) was added to each well, and then incubated at 25° C. for 15 minutes. Upon completion of the incubation, the absorbance at 405 nm was measured for the 96-well plate. Sample concentrations were determined by extrapolation from the generated standard curve. For shake flask analysis, representative transformants were inoculated into 2 ml of ura minus selection medium and incubated at 30° C., 250 rpm overnight. The overnight cultures were then diluted 200-fold in 25 ml of CUP minus ura medium in 125 ml glass shake flasks and grown for six days at 30° C. Samples were harvested, centrifuged at 12,000×g, in a microcentrifuge for 10 seconds, and supernatants tested for lipase activity using the p-nitrophenyl butyrate assay described above.
Ten microliters of culture supernatant were mixed with Laemmli Sample buffer (Bio-Rad Laboratories, Inc., Hercules, Calif., USA) in a 1:2 ratio. After boiling for 2 minutes, samples were loaded onto a 10-20% SDS-PAGE gel (Bio-Rad Laboratories, Inc., Hercules, Calif., USA) along with 15 μl of PRECISION PLUS PROTEIN™ Standards (Bio-Rad Laboratories, Inc., Hercules, Calif., USA). Gels were run in 1× Tris-glycine-SDS running buffer (Bio-Rad Laboratories, Inc., Hercules, Calif., USA) at 200 V for 1 hour. The gels were then rinsed 3 times with water for 5 minutes each, and stained with BIO-SAFE™ Coomassie Stain (Bio-Rad Laboratories, Inc., Hercules, Calif., USA) for 1 hour followed by destaining with water for at least 30 minutes.
Saccharomyces cerevisiae JG169 transformants containing pBM143b, pJLin195, pBM169a, or pBM171a (24 for each plasmid) were grown in “original” copper containing medium in 96-well plates for five days. Lipase activities in culture broth samples were assayed using p-nitrophenyl butyrate as a substrate as described above. The average relative lipase activities for pBM143b, pBM169a, pJLin195, and pBM171a transformants were 100, 202, 196, and 506, respectively, as shown in Table I.
The results shown in Table I indicated that by over-producing the Ace1p transcriptional activator with a high copy plasmid, Thermomyces lanuginosus variant lipase expression levels were doubled.
Thermomyces lanuginosus variant lipase activity in yeast transformants was shown to be improved for transformants grown in “optimal” medium containing succinic acid as a buffer and a mixture of galactose and glucose as the primary carbon source.
To test whether Thermomyces lanuginosus variant lipase expression levels in Ace1p over-producing transformants could be further enhanced in “optimal” medium, Thermomyces lanuginosus variant lipase activity was measured from Saccharomyces cerevisiae strain JG169 transformants containing pBM143b, pJLin195, pBM169a, or pBM171a grown in “original” or “optimal” copper containing medium in 96-well plates. All four expression plasmids were evaluated as described above.
The average relative lipase activities for pBM143b, pBM169a, pJLin195, and pBM171a transformants in “original” medium were 100, 190, 170, and 402, respectively. The average relative lipase activities for pBM143b, pBM169a, pJLin195, and pBM171a transformants grown in “optimal” medium were 240, 318, 285, and 266, respectively, as shown in Table II. Higher overall expression from transformants grown in “optimal” medium was observed from all plasmids. The effect of Ace1p overexpression on Thermomyces lanuginosus variant lipase production was approximately 30% higher when comparing plasmid pBM143b to plasmid pBM169a. However, over-expression of the ACE1 gene from pBM171a compared to pJLin195 in “optimal” medium resulted in a slight decrease in Thermomyces lanuginosus variant lipase expression.
Expression of Thermomyces lanuginosus variant lipase from pBM143b, pJLin195, pBM169a, or pBM171a was evaluated in shake flasks. Two representative transformants for each plasmid were grown in duplicate 25 ml shake flask cultures using “original” or “optimal” medium. Shake flask samples were harvested 4, 5, and 6 days. Supernatants from day 5 samples were assayed for Thermomyces lanuginosus variant lipase activity using the p-nitrophenyl butyrate assay described above.
In shake flasks, Thermomyces lanuginosus variant lipase expression due to the effect of over-expression of the ACE1 gene was approximately 1.1-fold higher when comparing pBM143b to pBM169a in “optimal medium” versus approximately 1.6-fold higher in “original” medium, in addition, over-expression of the ACE1 gene from pBM171a compared to pJLin195 in “original” medium resulted in an approximately 3.5-fold increase in expression, while a 1.6-fold decrease in expression in “optimal” medium was observed as shown in Table III. The relative expression levels of pBM171 transformants in both media were identical, whereas lipase expression levels among pJLin195 transformants were significantly higher in “optimal” medium. Growth was monitored as increasing culture turbidity (OD600) and by plating on agar medium to determine total CFU/ml. In general, cells in “original” medium grew at least twice as fast as cells grown in “optimal” medium, presumably due to the preference for glucose as a carbon source. Microscopically, yeast cells grown in “optimal” medium appeared bloated with large vacuoles having increased at least three-fold in size compared to yeast cells grown in “original” medium.
SDS-PAGE was performed, as described above, on supernatants from representative shake flasks and the intensities of the Thermomyces lanuginosus variant lipase bands were consistent with the p-nitrophenyl butyrate assay results.
Plasmids pBM165a and pBM170a were transformed into Saccharomyces cerevisiae JG169 cells, as described above. Transformants (24 for each plasmid) were selected and grown in “original” medium in 96-well plates as described above. The results demonstrated that the average relative lipase activities for pBM165a, pBM170a, and pBM169a transformants in “original” medium were 100, 277, and 173, respectively, as shown in Table IV.
By duplicating the primary binding sites for the Ace1p transcription factor and by increasing expression of the ACE1 gene from a multicopy plasmid, a 1.6-fold increase in Thermomyces lanuginosus variant lipase expression was observed in 96-well plates.
The invention described and claimed herein is not to be limited in scope by the specific embodiments herein disclosed, since these embodiments are intended as illustrations of several aspects of the invention. Any equivalent embodiments are intended to be within the scope of this invention. Indeed, various modifications of the invention in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. In the case of conflict, the present disclosure including definitions will control.
Various references including accession numbers are cited herein, the disclosures of which are incorporated by reference in their entireties.
Claims
1. A method for producing a polypeptide, comprising:
- (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first polynucleotide comprising a nucleic acid sequence encoding the polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter sequence, and a third polynucleotide comprising at least one copy of a gene encoding the copper-dependent trans-acting transcription factor; and
- (b) isolating the polypeptide from the cultivation medium.
2. The method of claim 1, wherein the copper-inducible promoter sequence is obtained from a gene selected from the group consisting of a Saccharomyces cerevisiae metallothienein gene, Saccharomyces cerevisiae superoxide dismutase gene, Saccharomyces cerevisiae cytosolic catalase gene, Saccharomyces cerevisiae copper resistant suppressor gene, Candida glabrata metallothionein gene, Neurospora crassa metallothionein gene, Yarrowia lipolytica metallothionein gene, Agaricus bisporus metallothionein gene, Magnaporthe grisea metallothionein gene, and Podospora anserina metallothionein gene.
3. The method of claim 1, wherein the one or more (several) additional copper-responsive upstream activation sequences are obtained from a gene selected from the group consisting of a Saccharomyces cerevisiae metallothienein gene, Saccharomyces cerevisiae superoxide dismutase gene, Saccharomyces cerevisiae cytosolic catalase gene, Saccharomyces cerevisiae copper resistant suppressor gene, Candida glabrata metallothionein gene, Neurospora crassa metallothionein gene, Yarrowia lipolytica metallothionein gene, Agaricus bisporus metallothionein gene, Magnaporthe grisea metallothionein gene, Podospora anserina metallothionein gene, and combinations thereof.
4. The method of claim 1, wherein the one or more (several) additional copper-responsive upstream activation sequences is SEQ ID NO: 46 and/or SEQ ID NO: 47.
5. The method of claim 1, wherein the copper-dependent trans-acting transcription factor gene is selected from the group consisting of a Saccharomyces cerevisiae ACE1 gene, Candida glabrata AMT1 gene, Yarrowia lipolytica CRF1 gene (Accession number P45815), Schizosaccharomyces pombe CUF2 gene (Accession number O94588), Saccharomyces cerevisiae HAA1 gene (Accession Number Q12753), and Aspergillus fumigatus copper fist DNA binding domain protein gene (Accession number Q4WN33).
6. The method of claim 1, wherein the fungal host cell contains one or more (several) copies of the first polynucleotide.
7. The method of claim 1, wherein the polypeptide is selected from the group consisting of an antigen, enzyme, growth factor, hormone, immunodilator, neurotransmitter, receptor, reporter protein, structural protein, and transcription factor.
8. The method of claim 1, wherein the polypeptide is an albumin, collagen, tropoelastin, elastin, or gelatin.
9. The method of claim 1, wherein the polypeptide is native or foreign to the fungal host cell.
10. The method of claim 1, wherein the first and second polynucleotides are contained in the chromosome of the fungal host cell or on an extrachromosomal element.
11. The method of claim 1, wherein the third polynucleotide is contained in the chromosome of the fungal host cell or on an extrachromosomal element.
12. The method of claim 1, wherein the fungal host cell is a filamentous fungal or yeast cell.
13. A polypeptide obtained by the method of claim 1.
14. A nucleic acid construct comprising a first polynucleotide comprising a nucleic acid sequence encoding a polypeptide operably linked to a copper-inducible promoter sequence comprising a copper-responsive upstream activation sequence activated by a copper-dependent trans-acting transcription factor and a second polynucleotide comprising one or more (several) additional copper-responsive upstream activation sequences operably linked upstream to the promoter sequence, wherein the promoter sequence is foreign to the nucleic acid sequence encoding the polypeptide and the copper-responsive upstream activation sequences are responsible for copper-induced transcription of the promoter.
15. The nucleic acid construct of claim 14, wherein the copper-inducible promoter sequence is obtained from a gene selected from the group consisting of a Saccharomyces cerevisiae metallothienein gene, Saccharomyces cerevisiae superoxide dismutase gene, Saccharomyces cerevisiae cytosolic catalase gene, Saccharomyces cerevisiae copper resistant suppressor gene, Candida glabrata metallothionein gene, Neurospora crassa metallothionein gene, Yarrowia lipolytica metallothionein gene, Agaricus bisporus metallothionein gene, Magnaporthe grisea metallothionein gene, and Podospora anserina metallothionein gene.
16. The nucleic acid construct of claim 14, wherein the one or more (several) additional copper-responsive upstream activation sequences are obtained from a gene selected from the group consisting of a Saccharomyces cerevisiae metallothienein gene, Saccharomyces cerevisiae superoxide dismutase gene, Saccharomyces cerevisiae cytosolic catalase gene, Saccharomyces cerevisiae copper resistant suppressor gene, Candida glabrata metallothionein gene, Neurospora crassa metallothionein gene, Yarrowia lipolytica metallothionein gene, Agaricus bisporus metallothionein gene, Magnaporthe grisea metallothionein gene, Podospora anserina metallothionein gene, and combinations thereof.
17. The nucleic acid construct of claim 14, wherein the one or more (several) additional copper-responsive upstream activation sequences is SEQ ID NO: 46 and/or SEQ ID NO: 47.
18. A recombinant expression vector comprising the nucleic acid construct of claim 14.
19. A recombinant fungal host cell comprising the nucleic acid construct of claim 14 and a third polynucleotide comprising at least one copy of a gene encoding a copper-dependent trans-acting transcription factor.
20. The recombinant fungal host cell of claim 19, wherein the copper-dependent trans-acting transcription factor gene is selected from the group consisting of a Saccharomyces cerevisiae ACE1 gene, Candida glabrata AMT1 gene, Yarrowia lipolytica CRF1 gene (Accession number P45815), Schizosaccharomyces pombe CUF2 gene (Accession number O94588), Saccharomyces cerevisiae HAA1 gene (Accession Number Q12753), and Aspergillus fumigatus copper fist DNA binding domain protein gene (Accession number Q4WN33).
Type: Application
Filed: Jul 13, 2007
Publication Date: Dec 24, 2009
Patent Grant number: 8940502
Applicants: Novozymes, Inc. (Davis, CA), Novozymes A/S (Bagsvaerd)
Inventors: Barbara Cherry (Davis, CA), Debbie Yaver (Davis, CA), Mads Bjornvad (Virum)
Application Number: 12/373,715
International Classification: C12P 21/02 (20060101); C07K 2/00 (20060101); C12N 15/11 (20060101); C12N 15/81 (20060101); C12N 1/15 (20060101);
